Table 4 Association of the TyG index and eGFR with the risk of cardiovascular diseases stratified by obesity, diabetes, hypertension and metabolic syndrome
From: Triglyceride-glucose index, renal function and cardiovascular disease: a national cohort study
| Â | HR (95% CI) | P value |
|---|---|---|
TyG < median & eGFR ≥ 60 | Ref |  |
Non obesity | ||
 TyG < median & eGFR < 60 | 1.301 (0.668–2.470) | 0.426 |
 TyG ≥ median & eGFR ≥ 60 | 1.122 (0.979–1.285) | 0.098 |
 TyG ≥ median & eGFR < 60 | 2.251 (1.257–4.048) | 0.006 |
Obesity | ||
 TyG < median & eGFR < 60 | 0.857 (0.121–4.085) | 0.856 |
 TyG ≥ median & eGFR ≥ 60 | 0.687 (0.215–1.887) | 0.491 |
 TyG ≥ median & eGFR < 60 | 1.296 (1.006–1.671) | 0.045 |
Non diabetes | ||
 TyG < median & eGFR < 60 | 1.089 (0.607–1.905) | 0.768 |
 TyG ≥ median & eGFR ≥ 60 | 1.129 (0.991–1.274) | 0.05 |
 TyG ≥ median & eGFR < 60 | 1.871 (1.061–3.289) | 0.029 |
Diabetes | ||
 TyG < median & eGFR < 60 | 1.564 (0.693–3.971) | 0.141 |
 TyG ≥ median & eGFR ≥ 60 | 1.225 (0.934–1.685) | 0.138 |
 TyG ≥ median & eGFR < 60 | 2.628 (1.784–3.338) | 0.045 |
Non hypertension | ||
 TyG < median & eGFR < 60 | 1.468 (0.706–2.991) | 0.293 |
 TyG ≥ median & eGFR ≥ 60 | 1.124 (0.975–1.296) | 0.107 |
 TyG ≥ median & eGFR < 60 | 1.480 (1.071–2.806) | 0.031 |
Hypertension | ||
 TyG < median & eGFR < 60 | 0.996 (0.415–2.241) | 0.993 |
 TyG ≥ median & eGFR ≥ 60 | 1.239 (1.048–1.464) | 0.012 |
 TyG ≥ median & eGFR < 60 | 2.079 (1.145–3.765) | 0.015 |
Non metabolic syndrome | ||
 TyG < median & eGFR < 60 | 1.254 (0.578–2.624) | 0.554 |
 TyG ≥ median & eGFR ≥ 60 | 1.044 (0.891–1.222) | 0.597 |
 TyG ≥ median & eGFR < 60 | 2.387 (1.581–3.214) | 0.048 |
Metabolic syndrome | ||
 TyG < median & eGFR < 60 | 1.214 (0.541–2.623) | 0.626 |
 TyG ≥ median & eGFR ≥ 60 | 1.295 (1.114–1.508) | 0.001 |
 TyG ≥ median & eGFR < 60 | 1.992 (1.191–3.323) | 0.008 |